IT8820741A0 - Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori. - Google Patents
Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori.Info
- Publication number
- IT8820741A0 IT8820741A0 IT8820741A IT2074188A IT8820741A0 IT 8820741 A0 IT8820741 A0 IT 8820741A0 IT 8820741 A IT8820741 A IT 8820741A IT 2074188 A IT2074188 A IT 2074188A IT 8820741 A0 IT8820741 A0 IT 8820741A0
- Authority
- IT
- Italy
- Prior art keywords
- monoclonal antibody
- antibody
- tumors
- diagnosis
- transformed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20741/88A IT1217724B (it) | 1988-05-26 | 1988-05-26 | Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori |
| EP89830234A EP0344134B1 (en) | 1988-05-26 | 1989-05-25 | Monoclonal antibody specific to a fibronectin sequence expressed in transformed cells, hybridoma secreting said antibody and use of said monoclonal antibody in the diagnosis of tumors |
| DE89830234T DE68912403T2 (de) | 1988-05-26 | 1989-05-25 | Monoklonaler Antikörper, spezifisch für eine in transformierten Zellen exprimierte Fibronectin-Sequenz, Hybridoma, das diesen Antikörper erzeugt und Verwendung dieses monoklonalen Antikörpers zur Diagnose von Tumoren. |
| AT89830234T ATE100471T1 (de) | 1988-05-26 | 1989-05-25 | Monoklonaler antikoerper, spezifisch fuer eine in transformierten zellen exprimierte fibronectinsequenz, hybridoma, das diesen antikoerper erzeugt und verwendung dieses monoklonalen antikoerpers zur diagnose von tumoren. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20741/88A IT1217724B (it) | 1988-05-26 | 1988-05-26 | Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8820741A0 true IT8820741A0 (it) | 1988-05-26 |
| IT1217724B IT1217724B (it) | 1990-03-30 |
Family
ID=11171367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT20741/88A IT1217724B (it) | 1988-05-26 | 1988-05-26 | Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP0344134B1 (it) |
| AT (1) | ATE100471T1 (it) |
| DE (1) | DE68912403T2 (it) |
| IT (1) | IT1217724B (it) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI892197A7 (fi) * | 1989-05-08 | 1990-11-09 | Locus Oy | Foerfarande foer detektering av tumoerer. |
| EP0522086B1 (en) * | 1990-03-12 | 1994-07-20 | The Biomembrane Institute | DNA SEQUENCE ENCODING GALACTOPROTEIN b3 |
| GB9610967D0 (en) | 1996-05-24 | 1996-07-31 | Cambridge Antibody Tech | Specific binding members,materials and methods |
| ES2590912T3 (es) | 1997-12-08 | 2016-11-24 | Merck Patent Gmbh | Proteínas de fusión heterodiméricas útiles para inmunoterapia dirigida y estimulación general del sistema inmunitario |
| GB9726539D0 (en) | 1997-12-16 | 1998-02-11 | Univ Dundee | Polypeptides, polynucleotides and uses thereof |
| HUP0204475A2 (en) | 2000-02-11 | 2003-04-28 | Merck Patent Gmbh | Enhancing the circulating half-life of antibody-based fusion proteins |
| JP2003524018A (ja) | 2000-02-24 | 2003-08-12 | アイトゲネーシシェ テクニシェ ホッホシューレ チューリッヒ | フィブロネクチンのed‐bドメインに特異的な抗体、前記抗体を含む複合体、および血管形成を検出および治療するためのその使用 |
| AU2001239470A1 (en) | 2000-02-24 | 2001-09-03 | Philogen S.R.L. | Compositions and methods for treatment of angiogenesis in pathological lesions |
| KR20030064275A (ko) | 2000-06-29 | 2003-07-31 | 메르크 파텐트 게엠베하 | 면역싸이토카인 흡수 증강제와의 조합 치료에 의한항체-싸이토카인 융합 단백질 매개 면역 반응 증강 |
| RU2003129528A (ru) | 2001-03-07 | 2005-04-10 | Мерк Патент ГмбХ (DE) | Способ экспрессии белков, содержащих в качестве компонента гибридный изотип антитела |
| EP1383785B1 (en) | 2001-05-03 | 2011-03-16 | Merck Patent GmbH | Recombinant tumor specific antibody and use thereof |
| DK1454138T3 (da) | 2001-12-04 | 2012-02-13 | Merck Patent Gmbh | Immunocytokiner med moduleret selektivitet |
| RU2370276C2 (ru) | 2003-12-31 | 2009-10-20 | Мерк Патент Гмбх | Fc-ЭРИТРОПОЭТИН СЛИТЫЙ БЕЛОК С УЛУЧШЕННОЙ ФАРМАКОКИНЕТИКОЙ |
| EP1702069A2 (en) | 2004-01-05 | 2006-09-20 | EMD Lexigen Research Center Corp. | Interleukin-12 targeted to oncofoetal fibronectin |
| AU2005206277B2 (en) | 2004-01-22 | 2011-06-23 | Merck Patent Gmbh | Anti-cancer antibodies with reduced complement fixation |
| US7785591B2 (en) | 2004-10-14 | 2010-08-31 | Morphosys Ag | Identification and characterization of function-blocking anti-ED-B-fibronectin antibodies |
| ES2365046T3 (es) | 2005-12-30 | 2011-09-21 | Merck Patent Gmbh | Anticuerpos anti-cd19 con inmunogenicidad reducida. |
| WO2008120101A2 (en) | 2007-04-02 | 2008-10-09 | Philogen S.P.A. | The ed-a antigen of fibrinogen is associated with the neovasculature of tumour metastases |
| US10202442B2 (en) | 2007-07-25 | 2019-02-12 | Philogen S.P.A. | Antigen associated with lung cancers and lymphomas |
| DK3281952T3 (da) | 2007-10-30 | 2020-08-03 | Philogen Spa | Antigen, der er forbundet med reumatoid artritis |
| EP2100621A1 (en) | 2008-03-10 | 2009-09-16 | mivenion GmbH | Polyether polyol dendron conjugates with effector molecules for biological targeting |
| EP2461832B1 (en) | 2009-08-05 | 2017-06-28 | Philogen S.p.A. | Targeting of bone marrow neovasculature |
| ES2743423T3 (es) | 2012-10-03 | 2020-02-19 | Philogen Spa | Conjugado de anticuerpos para su uso en el tratamiento de una enfermedad inflamatoria intestinal |
-
1988
- 1988-05-26 IT IT20741/88A patent/IT1217724B/it active
-
1989
- 1989-05-25 EP EP89830234A patent/EP0344134B1/en not_active Expired - Lifetime
- 1989-05-25 AT AT89830234T patent/ATE100471T1/de not_active IP Right Cessation
- 1989-05-25 DE DE89830234T patent/DE68912403T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE68912403D1 (de) | 1994-03-03 |
| EP0344134A2 (en) | 1989-11-29 |
| ATE100471T1 (de) | 1994-02-15 |
| EP0344134A3 (en) | 1990-08-08 |
| IT1217724B (it) | 1990-03-30 |
| EP0344134B1 (en) | 1994-01-19 |
| DE68912403T2 (de) | 1994-05-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT8820741A0 (it) | Anticorpo monoclonale specifico per una sequenza di fibronettina espressa in cellule trasformate ibridoma secernente tale anticorpo e impiego dell'anticorpo monoclonale per la diagnosi di tumori. | |
| FI954347L (fi) | Monoklonaaliset vasta-ainekoostumukset ja monoklonaalisia vasta-aineita tuottavat hybridomat | |
| FI893300A7 (fi) | Ihmisen B-solun pinta-antigeenille spesifinen kimeerinen vasta-aine | |
| IT1245748B (it) | Preparazione includente anticorpi monoclonali biotinilati, avidina e biotina, per la diagnosi di affezioni tumorali e suo impiego | |
| IL67721A (en) | Hybridoma cell lines,their preparation and their use for the production of human monoclonal antibodies | |
| KR900702007A (ko) | T세포 항원 수용체의 지어부위와 반응하는 단클론항체 | |
| NO162179C (no) | Monoklonale antistoffer for anvendelse in vitro. | |
| IT8220138A0 (it) | Procedimento di coltivazione di cellule dipendenti dell'ancoraggio. | |
| IT1207589B (it) | Composizione di anticorpi monoclonali umani cross-protettivi. | |
| DE3788148D1 (de) | Monoklonale Antikörper und deren Verwendung. | |
| EP0341684A3 (en) | Human monoclonal antibody, hybridoma producing the same and pharmaceutical | |
| FI893475A7 (fi) | Monoklonaalinen vasta-aine endoteelisolujen RGD-suunnattua adheesiores ptoria vastaan | |
| DK191989D0 (da) | Tumor-associeret glycoproteinantigen, antistoffer mod antigenet samt hybridoma-cellelinie, der producerer antistofferne | |
| IT8567383A0 (it) | Corpo monoclonale e saggi immunolo procedimento per la preparazione di gici con l impiego di detto determi un determinante bispecifico di anti nante | |
| FI895287A7 (fi) | Fukosyylikeramidin vastainen monoklonaalinen vasta-aine | |
| ZA852426B (en) | Monoclonal antibody specific for human basal cell surface antigen | |
| DE3587714D1 (de) | Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper. | |
| FI902735A7 (fi) | Monoklonaalinen vasta-aine, joka reagoi tiettyyn laajasti erilaisissa ihmisleukemia- ja lymfomasoluissa esiintyvään antigeeniin ja menetelmä sen käyttämiseksi diagnoosiin ja hoitoon | |
| AU5809290A (en) | Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application | |
| DK717888D0 (da) | Monoklonale antistoffer | |
| NO890116D0 (no) | Monoklonale antistoffer. | |
| FI894551A7 (fi) | Hybridiset monoklonaaliset vasta-aineet, niiden valmistus ja käyttö | |
| DE3580524D1 (de) | Monoklonaler antikoerper geeignet zur spezifischen unterscheidung von humanen hepatokarzinomzellen. | |
| IT1239065B (it) | Anticorpo monoclonale che inibisce l'azione biologica del fattore piastrinico 4 | |
| FR2621127B1 (fr) | Anticorps monoclonal reconnaissant un epitope de la chaine gamma des recepteurs de surface des cellules t humaines, lignee de cellules d'hybridomes produisant cet anticorps, et utilisation de cet anticorps monoclonal |